Announcements Trials
Browse Landscape

Status

Completed 12Terminated 5Recruiting 5Withdrawn 2Unknown 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 160Lymphoid 25Plasma cell 13Myeloid 10Classical hematology 5Thoracic 1Sarcoma 1Other neoplasm 1Other 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Sarcoma 163Osteosarcoma 56Gastrointestinal Stromal Tumors 40Bone Neoplasms 32Glioblastoma 22Gliosarcoma 21Sarcoma, Ewing 20Dendritic Cell Sarcoma, Interdigitating 20Lymphoma 19Brain Neoplasms 18Neoplasms 17Central Nervous System Neoplasms 17Stomach Neoplasms 16Breast Neoplasms 16Ovarian Neoplasms 15Leiomyosarcoma 15Rhabdomyosarcoma 13Neuroblastoma 13Neoplasm Metastasis 13Recurrence 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Pancreatic Neoplasms 12Liposarcoma 12Astrocytoma 12Esophageal Neoplasms 11Chondrosarcoma 11Burkitt Lymphoma 11Sarcoma, Synovial 10Oligodendroglioma 9Neurofibrosarcoma 9

Interventions

glucarpidase 1Methotrexate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Hematologic Neoplasms × Sarcoma × Clear all
NCT05899751 2024-05-10

Retrospective Registry Study of Patients With Cancer Treated With High-dose Methotrexate

BTG International Inc.

Unknown
1,000 enrolled
GenitourinaryOther hematologic neoplasmSarcoma

Osteosarcoma, Water Intoxication, Hematologic Neoplasms, Acute Kidney Injury, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡